Logo image
Stereotactic Radiosurgery with Versus without Embolization for Brain Arteriovenous Malformations
Journal article   Open access

Stereotactic Radiosurgery with Versus without Embolization for Brain Arteriovenous Malformations

Ching-Jen Chen, Dale Ding, Cheng-Chia Lee, Kathryn N. Kearns, I. Jonathan Pomeraniec, Christopher P. Cifarelli, David E. Arsanious, Roman Liscak, Jaromir Hanuska, Brian J. Williams, …
Neurosurgery, Vol.88(2)
2021

Abstract

Adult Cohort Studies Embolization, Therapeutic Female Humans Intracranial Arteriovenous Malformations Male Middle Aged Radiosurgery Retrospective Studies Treatment Outcome enbucrilate ethylene vinyl alcohol copolymer polyvinyl alcohol silk adult all cause mortality Article artificial embolization bleeding brain arteriovenous malformation brain cyst cohort analysis comparative effectiveness controlled study female human intermethod comparison major clinical study male priority journal radiation injury retrospective study stereotactic radiosurgery treatment outcome artificial embolization brain arteriovenous malformation middle aged procedures radiosurgery
BACKGROUND: Prior comparisons of brain arteriovenous malformations (AVMs) treated using stereotactic radiosurgery (SRS) with or without embolization were inherently flawed, due to differences in the pretreatment nidus volumes. OBJECTIVE: To compare the outcomes of embolization and SRS, vs SRS alone for AVMs using pre-embolization malformation features. METHODS: We retrospectively reviewed International Radiosurgery Research Foundation AVM databases from 1987 to 2018. Patients were categorized into the embolization and SRS (E + SRS) or SRS alone (SRS-only) cohorts. The 2 cohorts were matched in a 1:1 ratio using propensity scores. Primary outcome was defined as AVM obliteration. Secondary outcomes were post-SRS hemorrhage, all-cause mortality, radiologic and symptomatic radiation-induced changes (RIC), and cyst formation. RESULTS: The matched cohorts each comprised 101 patients. Crude AVM obliteration rates were similar between the matched E + SRS vs SRS-only cohorts (48.5% vs 54.5%; odds ratio = 0.788, P =. 399). Cumulative probabilities of obliteration at 3, 4, 5, and 6 yr were also similar between the E + SRS (33.0%, 46.4%, 56.2%, and 60.8%, respectively) and SRS-only (32.9%, 46.2%, 56.0%, and 60.6%, respectively) cohorts (subhazard ratio (SHR) = 1.005, P =. 981). Cumulative probabilities of radiologic RIC at 3, 4, 5, and 6 yr were lower in the E + SRS (25.0%, 25.7%, 26.7%, and 26.7%, respectively) vs SRS-only (45.3%, 46.2%, 47.8%, and 47.8%, respectively) cohort (SHR = 0.478, P =. 004). Symptomatic and asymptomatic embolization-related complication rates were 8.3% and 18.6%, respectively. Rates of post-SRS hemorrhage, all-cause mortality, symptomatic RIC, and cyst formation were similar between the matched cohorts. CONCLUSION: This study refutes the prevalent notion that AVM embolization negatively affects the likelihood of obliteration after SRS. Copyright © 2020 by the Congress of Neurological Surgeons.
url
https://doi.org/10.1093/neuros/nyaa418View
Published (Version of record) Open

Details

Logo image